Xenon Pharmaceuticals (XENE)
(Delayed Data from NSDQ)
$41.01 USD
+0.64 (1.59%)
Updated Aug 8, 2024 04:00 PM ET
After-Market: $41.02 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | *AMC8/8/24 |
---|---|
Current Quarter | -0.72 |
EPS Last Quarter | -0.62 |
Last EPS Surprise | 10.14% |
ABR | 1.12 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.98 |
Next Year | -3.41 |
EPS (TTM) | -2.71 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 25.00M | 75.00M |
# of Estimates | NA | NA | 1 | 1 |
High Estimate | NA | NA | 25.00M | 75.00M |
Low Estimate | NA | NA | 25.00M | 75.00M |
Year ago Sales | 0.00M | 0.00M | 9.43M | 25.00M |
Year over Year Growth Est. | NA | NA | 165.00% | 200.00% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.72 | -0.77 | -2.98 | -3.41 |
# of Estimates | 7 | 6 | 10 | 9 |
Most Recent Consensus | -0.67 | -0.71 | -3.33 | -4.28 |
High Estimate | -0.63 | -0.65 | -2.58 | -2.10 |
Low Estimate | -0.82 | -0.93 | -3.40 | -4.28 |
Year ago EPS | -0.72 | -0.73 | -2.73 | -2.98 |
Year over Year Growth Est. | 0.00% | -5.48% | -9.16% | -14.60% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.72 | -0.77 | -2.98 | -3.41 |
7 Days Ago | -0.72 | -0.77 | -2.98 | -3.41 |
30 Days Ago | -0.72 | -0.77 | -2.98 | -3.41 |
60 Days Ago | -0.72 | -0.77 | -2.98 | -3.41 |
90 Days Ago | -0.71 | -0.76 | -3.02 | -3.42 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.72 | -0.77 | -2.98 | -3.41 |
Zacks Consensus Estimate | -0.72 | -0.77 | -2.98 | -3.41 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.62 | -0.64 | -0.73 | -0.72 | NA |
Estimate | -0.69 | -0.76 | -0.75 | -0.69 | NA |
Difference | 0.07 | 0.12 | 0.02 | -0.03 | 0.05 |
Surprise | 10.14% | 15.79% | 2.67% | -4.35% | 6.06% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more